BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37999237)

  • 1. PPA1 Deficiency Causes a Deranged Galactose Metabolism Recognizable in Neonatal Screening.
    Achleitner MT; Jans JJM; Ebner L; Spenger J; Konstantopoulou V; Feichtinger RG; Brugger K; Mayr D; Wevers RA; Thiel C; Wortmann SB; Mayr JA
    Metabolites; 2023 Nov; 13(11):. PubMed ID: 37999237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Critical Elements for Regulation of Inorganic Pyrophosphatase (PPA1) in MCF7 Breast Cancer Cells.
    Mishra DR; Chaudhary S; Krishna BM; Mishra SK
    PLoS One; 2015; 10(4):e0124864. PubMed ID: 25923237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective galactose culture condition reveals distinct metabolic signatures in pyruvate dehydrogenase and complex I deficient human skin fibroblasts.
    Hertig D; Felser A; Diserens G; Kurth S; Vermathen P; Nuoffer JM
    Metabolomics; 2019 Feb; 15(3):32. PubMed ID: 30830487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrophosphatase 1 expression is associated with future recurrence and overall survival in Chinese patients with intrahepatic cholangiocarcinoma.
    Xu D; Miao Y; Gu X; Wang J; Yu G
    Oncol Lett; 2018 May; 15(5):8095-8101. PubMed ID: 29740496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vacuolar H
    Segami S; Tomoyama T; Sakamoto S; Gunji S; Fukuda M; Kinoshita S; Mitsuda N; Ferjani A; Maeshima M
    Plant Cell; 2018 May; 30(5):1040-1061. PubMed ID: 29691313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallographic and modeling study of the human inorganic pyrophosphatase 1: A potential anti-cancer drug target.
    Niu H; Zhu J; Qu Q; Zhou X; Huang X; Du Z
    Proteins; 2021 Jul; 89(7):853-865. PubMed ID: 33583053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Inorganic Pyrophosphatase (PPA1) Correlates with Poor Prognosis of Epithelial Ovarian Cancer.
    Li H; Xiao N; Li Z; Wang Q
    Tohoku J Exp Med; 2017 Feb; 241(2):165-173. PubMed ID: 28202851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPA1 regulates tumor malignant potential and clinical outcome of colon adenocarcinoma through JNK pathways.
    Wang P; Zhou Y; Mei Q; Zhao J; Huang L; Fu Q
    Oncotarget; 2017 Aug; 8(35):58611-58624. PubMed ID: 28938583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Galactose Index measured in fibroblasts of GALT deficient patients distinguishes variant patients detected by newborn screening from patients with classical phenotypes.
    Welsink-Karssies MM; van Weeghel M; Hollak CEM; Elfrink HL; Janssen MCH; Lai K; Langendonk JG; Oussoren E; Ruiter JPN; Treacy EP; de Vries M; Ferdinandusse S; Bosch AM
    Mol Genet Metab; 2020 Mar; 129(3):171-176. PubMed ID: 31954591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inorganic pyrophosphatase 1 activates the phosphatidylinositol 3-kinase/Akt signaling to promote tumorigenicity and stemness properties in colorectal cancer.
    Niu T; Zhu J; Dong L; Yuan P; Zhang L; Liu D
    Cell Signal; 2023 Aug; 108():110693. PubMed ID: 37141926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPA1 Regulates Systemic Insulin Sensitivity by Maintaining Adipocyte Mitochondria Function as a Novel PPARγ Target Gene.
    Yin Y; Wu Y; Zhang X; Zhu Y; Sun Y; Yu J; Gong Y; Sun P; Lin H; Han X
    Diabetes; 2021 Jun; 70(6):1278-1291. PubMed ID: 33722839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Importance of Neonatal Screening for Galactosemia.
    Badiu Tișa I; Achim AC; Cozma-Petruț A
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of Vacuolar H
    Fukuda M; Mieda M; Sato R; Kinoshita S; Tomoyama T; Ferjani A; Maeshima M; Segami S
    Front Plant Sci; 2020; 11():655. PubMed ID: 32528505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPA1, an energy metabolism initiator, plays an important role in the progression of malignant tumors.
    Wang S; Wei J; Li S; Luo Y; Li Y; Wang X; Shen W; Luo D; Liu D
    Front Oncol; 2022; 12():1012090. PubMed ID: 36505776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of PPA1 inhibitor candidates for potential repurposing in cancer medicine.
    Menteş M; Yandım C
    J Cell Biochem; 2023 Oct; 124(10):1646-1663. PubMed ID: 37733630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful diagnosis of HIBCH deficiency from exome sequencing and positive retrospective analysis of newborn screening cards in two siblings presenting with Leigh's disease.
    Stiles AR; Ferdinandusse S; Besse A; Appadurai V; Leydiker KB; Cambray-Forker EJ; Bonnen PE; Abdenur JE
    Mol Genet Metab; 2015 Aug; 115(4):161-7. PubMed ID: 26026795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galactosemia: when is it a newborn screening emergency?
    Berry GT
    Mol Genet Metab; 2012 May; 106(1):7-11. PubMed ID: 22483615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing PPA1 inhibits human epithelial ovarian cancer metastasis by suppressing the Wnt/β-catenin signaling pathway.
    Niu H; Zhou W; Xu Y; Yin Z; Shen W; Ye Z; Liu Y; Chen Y; Yang S; Xiang R; Wang L; Qu P
    Oncotarget; 2017 Sep; 8(44):76266-76278. PubMed ID: 29100310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inorganic pyrophosphatase (PPA1) is a negative prognostic marker for human gastric cancer.
    Yang Y; Cai J; Yin J; Wang D; Bai Z; Zhang J; Wang K; Yu G; Zhang Z
    Int J Clin Exp Pathol; 2015; 8(10):12482-90. PubMed ID: 26722435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of neurite growth by inorganic pyrophosphatase 1 via JNK dephosphorylation.
    Tezuka Y; Okada M; Tada Y; Yamauchi J; Nishigori H; Sanbe A
    PLoS One; 2013; 8(4):e61649. PubMed ID: 23626709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.